You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東瑞製藥(02348.HK)擬5560萬元出售蘇州新申醫藥科技35%股權
格隆匯 01-26 21:37

格隆匯1月26日丨東瑞製藥(02348.HK)公吿,於2022年1月26日,賣方東瑞國際股份有限公司(公司間接全資附屬公司)、買方蘇州融新建設發展有限公司與目標公司蘇州新申醫藥科技有限公司訂立買賣協議,據此,賣方同意出售而買方同意收購銷售股權,相當於目標公司的35%股權,代價約為人民幣5560萬元。於完成後,公司將不再於目標公司擁有任何股權。

目標公司的主要業務為向集團位於中國蘇州的生產工廠提供溶媒回收服務。隨着該工廠遷至蘇州市吳中經濟技術開發區的另一地段,目標公司的溶媒回收業務已於2021年12月終止,而根據集團目前所得資料,買方可能於完成出售事項後向有關當局申請變更經營範圍。

出售集團於目標公司的權益為集團將於蘇州的生產工廠遷往具有綜合溶媒回收功能的新設施的一部分。隨着搬遷完成及目標公司於2021年終止營運,董事認為透過出售事項出售其於目標公司舊有生產工場的餘下權益並調配有關出售事項的所得款項淨額作發展本集團現有業務是符合集團最佳利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account